Search Results

Claris GenomiX Looks to Transform Precision Oncology Through Its Groundbreaking mRNA-Based Diagnostics

Claris GenomiX Looks to Transform Precision Oncology Through Its Groundbreaking mRNA-Based Diagnostics.

December 12, 2023

·

3 min read

Pharm Country

Claris Bio Emerges From Stealth With a New Investor and Prepares for Next Development Stage With Late-Stage Data Expected in 1H24

Claris Bio unveiled the company and its lead program, with a total of $57 million invested from Series A investors Novo Holdings A/S, RA Capital and Mass General Brigham Ventures and recent investor, Janus Henderson Investors.

January 4, 2024

·

4 min read

Claris GenomiX announces licensing availability of ColoType, its patented mRNA-based Consensus Molecular Subtyping (CMS) assay for guiding colorectal cancer treatment decisions

Claris GenomiX, Inc. announced today that ColoType, its patented mRNA-based cancer diagnostic, is available for exclusive licensing.

November 16, 2023

·

2 min read

Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity

Resalis Therapeutics announced the closing of a €10 million Series A financing round led by Sunstone Life Science Ventures with participation from existing investors including Claris Ventures and angel investors.

January 4, 2024

·

4 min read

Business

Parexel Teams with CLARINESS to Enhance Patient Access and Engagement in China

Collaboration expands Parexel’s capabilities in the region for patient access through China’s native social media channels; enhances ongoing engagement through CLARINESS’s digital patient recruitment portal

June 12, 2019

·

3 min read

Press Releases

ClariMed Inc. Strengthens Leadership Team with Joe Dobkin as New VP of Services

October 2, 2024

·

2 min read

I will help you! Hands of a man and a woman in neon light. Art collage. Metaphor of rescue.

Venture Capitalists

While Major VCs Raise Billions, Smaller Funds Swoop In for Early-Stage Science

Big-name venture capital firms are raising billions again, though funding a small number of de-risked companies. Meanwhile, smaller VC firms are catching the less flashy companies they think could be future pillars of the sector.

October 30, 2024

·

6 min read

·

Annalee Armstrong

Press Releases

ALKemist Bio Appoints Adi Hoess to Board of Directors

December 17, 2024

·

3 min read

Business

Evotec Reports Q1 2024 Results and Provides Corporate Update